Prelude Capital Management, LLC Edwards Lifesciences Corp Transaction History

Prelude Capital Management, LLC

$1.39 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $176,552 - $222,471	2,861 New	2,861 $218,000
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $250,579 - $290,347	-3,078 Reduced 35.01%	5,715 $539,000
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $297,262 - $338,293	4,003 Added 83.57%	8,793 $727,000
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $85,853 - $109,912	1,257 Added 35.58%	4,790 $357,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $291,013 - $379,055	3,533 New	3,533 $292,000
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $366,231 - $449,931	-3,443 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $354,319 - $422,628	3,443 New	3,443 $390,000
Q2 2020 Aug 14, 2020	SELL	$57.54 - $76.95 $37,343 - $49,940	-649 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $253,192 - $391,311	-4,831 Reduced 88.16%	649 $122,000
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $374,345 - $428,591	5,221 Added 2015.83%	5,480 $1.28 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $15,941 - $19,536	259 New	259 $57,000
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $237,062 - $273,935	-4,253 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $203,676 - $272,404	4,253 New	4,253 $814,000
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $25,989 - $31,886	-560 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $409,152 - $519,542	-8,953 Reduced 94.11%	560 $97,000
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $35,148 - $42,476	828 Added 9.53%	9,513 $1.39 Million
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $27,632 - $35,255	743 Added 9.36%	8,685 $1.21 Million
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $268,360 - $312,835	7,942	7,942 $895,000

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

470M

Call Options Held

2.44M

Put Options Held

2.65M

Vanguard Group Inc Valley Forge, PA

53.6M
Shares

$3.6 Billion
0.1% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.43 Billion
0.11% of portfolio
State Street Corp Boston, MA

26M
Shares

$1.75 Billion
0.11% of portfolio
Alliancebernstein L.P. New York, NY

20.3M
Shares

$1.37 Billion
0.68% of portfolio
Wellington Management Group LLP Boston, MA

16.9M
Shares

$1.14 Billion
0.29% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account